Bivalirudin for Injection 250 mg (Bivalirudin POWDER FOR SOLUTION) 250 MG

Bivalirudin for Injection 250 mg is a powder for solution used for anticoagulation. This medication is administered intravenously and is manufactured by Formative Pharma Inc. in Canada.

Strength

250 MG

Manufacturer / TM Owner

FORMATIVE PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bivalirudin for Injection 250 mg is generally used for anticoagulation purposes. It is often utilized in procedures where blood clotting needs to be controlled, such as during certain medical interventions. The primary use of bivalirudin is to prevent blood clots from forming in the blood vessels. It is important to consult with a healthcare provider to understand the specific uses of this medication.

Side Effects

Bivalirudin for Injection 250 mg works by inhibiting the action of thrombin, an enzyme that plays a crucial role in blood clotting. This can help to prevent the formation of blood clots. Common effects may include changes in blood pressure and heart rate, as well as potential bleeding at the injection site. Always monitor for any unusual symptoms and consult a healthcare provider if necessary.

Precautions & Warnings

Bivalirudin for Injection 250 mg should be handled with care. It is important to follow proper administration procedures to avoid complications. Patients with a history of bleeding disorders or those taking other anticoagulants should use this medication with caution. Always store the medication as directed and ensure it is used within its expiration date.

Avoid Interactions

Bivalirudin for Injection 250 mg may interact with other medications, particularly those that affect blood clotting. This includes other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should also be avoided as it can increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Bivalirudin is generally used for anticoagulation purposes, particularly during medical procedures where blood clotting needs to be controlled.

Bivalirudin is administered intravenously as a powder for solution.

Common effects may include changes in blood pressure and heart rate, as well as potential bleeding at the injection site.

Yes, bivalirudin may interact with other medications that affect blood clotting, including other anticoagulants and NSAIDs.

Patients with a history of bleeding disorders or those taking other anticoagulants should use bivalirudin with caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.